Vimarsana
Biggest News Aggregation in the World

Page 30 - Scientific Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scientific Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scientific Program Today - Breaking & Trending Today

Researchers to develop standard method for sharing AMR data - Vimarsana News

Researchers to develop standard method for sharing AMR data

Providing veterinarians, producers more tools to identify, treat bacterial infections in livestock, data will help improve antimicrobial use decision making.

Researchers to develop standard method for sharing AMR data - Vimarsana News

Researchers to develop standard method for sharing AMR data

Providing veterinarians, producers more tools to identify, treat bacterial infections in livestock, data will help improve antimicrobial use decision making.

Image of the Year and Research Announced at SNMMI 2023 on Theranostic Pair for Early Detection and Effective Treatment of Pancreatic Cancer - Vimarsana News

Image of the Year and Research Announced at SNMMI 2023 on Theranostic Pair for Early Detection and Effective Treatment of Pancreatic Cancer

During its 2023 Annual Meeting, the Image of the Year was selected by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), and represents research presented which reports on the ability of a novel theranostic pair to successfully detect metastatic pancreatic cancer and provide a means of selecting appropriate treatments.

Profound Medical Corp. (NASDAQ:PROF) Q1 2023 Earnings Call Transcript - Vimarsana News

Profound Medical Corp. (NASDAQ:PROF) Q1 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Profound Medical First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Year-End 2022 Update on Operations - Vimarsana News

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Year-End 2022 Update on Operations

Initiated patient enrollment in a Phase II open-label clinical trial investigating the safety, tolerability, and efficacy of CardiolRx in patients with recurrent pericarditis - a debilitating heart disease